ataluren

News
PTC-Logo

Translarna not approved by NICE for DMD on NHS

In draft guidance published on Friday, it emerged NICE does not recommend PTC Therapeutics’ Translarna (ataluren) for the treatment of Duchenne muscular dystrophy (DMD) caused by a nonsense